NAB Capital Notes 2

National Australia Bank (“NAB”) announced this morning its intention to raise $750 million (with the ability to raise more or less) through the issue of NAB Capital Notes 2. NAB is issuing the Notes to raise regulatory capital which will qualify as...

Trading Idea: Mayne Pharma Group MYX

Gain exposure to the US market, diversify your portfolio with an Australian Pharmaceutical company, gain exposure to a weakening $AUD Mayne Pharma is an emerging pharmaceutical manufacturer – with direct distribution into US generics markets Mayne Pharma Group...